A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation of VX-993
NCT06508762 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2024-10-10
Summary
The purpose of the study is to evaluate the pharmacokinetics (PK), safety, and tolerability of VX-993 in healthy adult participants.
Conditions
Interventions
- DRUG
-
VX-993
Tablet and Suspension for Oral Administration.
Sponsors & Collaborators
-
Vertex Pharmaceuticals Incorporated
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-07-26
- Primary Completion
- 2024-09-10
- Completion
- 2024-09-10
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study to Assess the Relative Bioavailability of Three Immediate-Release Tablet Formulations of ABBV-903 in Healthy Adult Volunteers
NCT06078202 ·Status: WITHDRAWN ·Phase: PHASE1
-
Relative Bioavailability Study of 4 Different Formulations of PF-07321332 Relative to the Commercial Tablet Formulation
NCT05263895 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Relative Bioavailability of Immediate Release Formulations of ABBV-903 in Healthy Adult Participants
NCT05836506 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of Single Rising Doses and Relative Bioavailability of BI 691751
NCT01843972 ·Status: COMPLETED ·Phase: PHASE1
-
To Investigate the Safety, Tolerability, Pharmacokinetics and the Relative Bioavailability of BI 1026706
NCT01763333 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult Participants
NCT06849791 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Bioavailability and Pharmacokinetics of BI 10773 Tablet in Healthy Male Volunteers
NCT02172209 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Volunteers
NCT05467696 ·Status: COMPLETED ·Phase: PHASE1
-
A Human Phase I Absolute Bioavailability Study of PRT054021 in Healthy Male Volunteers
NCT01765868 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability Study of PF-06651600 Formulations in Healthy Participants
NCT04004663 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Food Effect of Venetoclax New Tablet Formulation in Healthy Female Participants
NCT06070948 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses and Effect of Food on the Bioavailability of BI 1060469
NCT01971502 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of a BI 187004 Tablet Formulation in Comparison With an Oral Solution and the Influence of Food on the Tablet Formulation in Healthy Volunteers
NCT02161432 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants
NCT07226817 ·Status: RECRUITING ·Phase: PHASE1
-
Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female Subjects
NCT01053520 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Bioavailability of BMS-986205
NCT03374228 ·Status: COMPLETED ·Phase: PHASE1
-
Food Effect of VS-6766 in Healthy Adult Subjects
NCT05187169 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-97489 in Healthy Adult Participants
NCT05099822 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Evaluate the Relative Bioavailability of Povetacicept Formulations and Bioequivalence of Povetacicept Presentations
NCT07010406 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Relative Bioavailability of BMS-986435 Formulations in Healthy Adult Participants
NCT06577259 ·Status: COMPLETED ·Phase: PHASE1
-
An Investigational Study to Evaluate Experimental Medication BMS-986165 Given as a Tablet and Solution in Healthy Male Participants
NCT03739788 ·Status: COMPLETED ·Phase: PHASE1
-
Food Effect Study of CTP-543 in Healthy Volunteers
NCT03880136 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol
NCT00768274 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Assess Adverse Events and Compare How Crushed, Ground, and Intact Oral Tablets Venetoclax Moves Through the Body of Healthy Female Adult Volunteers
NCT05909553 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Determine the Bioavailability and Food Effect of a Single TAK-935 Dose in Healthy Participants
NCT02906813 ·Status: COMPLETED ·Phase: PHASE1